By proceeding, you agree to our Terms of Use and Privacy Policy.
Hongene Biotech Corporation was established in 1998 as an R&D organization and has since become a manufacturer with state-of-art facilities in the fields of nucleosides, nucleotides and phosphoramidites. Having main operations in Shanghai, China at the start, today the company also has offices and laboratories in the USA and Japan. Hongene supplies only the best quality products at a competitive price to customers worldwide. Through collaborations with pharmaceutical diagnostic and biotechnology companies, Hongene is continuously developing new products in this area of science.
07-10 May 2023
Join the TIDES conference from May 7-10, 2023, either in-person or digitally, at the Manchester Grand Hyatt San Diego. This conference is the industry's largest and most prestigious event for accelerating oligo and peptide therapeutics to market, wit
Event Ended
Hybrid
Paid
San Diego
06-07 September 2023
LSX are known for bringing life science investors together to assess and meet with the most promising up-and-coming biotech companies. When the first mRNA vaccines hit the market in 2020, one of our investors asked us to look at the resurgence of the
USA
Boston